Cancer clinical trials in Zurich
163 open trials with at least one site in Zurich, according to ClinicalTrials.gov, updated on October 28, 2026.
These results are indicative and do not replace medical advice — discuss them with your doctor.
Open trials
- A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
NCT05765812RecruitingPhase 1 · Phase 2
- Observational Study Protocol: LIVER-R
NCT06252753Recruiting
- Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%
NCT07020065RecruitingPhase 2
- Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
NCT07365423RecruitingPhase 2
- A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
NCT05916313RecruitingPhase 1
- OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
NCT06466382Recruiting
- MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
NCT07574047RecruitingPhase 2
- Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.
NCT07593482RecruitingPhase 2
- A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
NCT07190248RecruitingPhase 3
- International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
NCT07476729RecruitingPhase 3
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
NCT03970447RecruitingPhase 2 · Phase 3
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
NCT05920356RecruitingPhase 3
- Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
NCT06358573RecruitingPhase 2
- A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT06499285RecruitingPhase 3
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
NCT07293351RecruitingPhase 1 · Phase 2
- The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NCT05890677Recruiting
- An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
NCT05939414RecruitingPhase 3
- A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
NCT07213674RecruitingPhase 3
- Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial
NCT07840456Not yet recruitingPhase 2
- AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07611110RecruitingPhase 3
- PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
NCT04790253Recruiting
- A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT06925737RecruitingPhase 3
- Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
NCT07140172Recruiting
- A Beta-only IL-2 ImmunoTherapY Study
NCT05086692RecruitingPhase 1 · Phase 2
- A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
NCT06312176RecruitingPhase 3
- Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
NCT06393374RecruitingPhase 3
- DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
NCT06989112RecruitingPhase 3
- Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT06401980RecruitingPhase 2
- European Real-World Registry for Use of the Ion Endoluminal System
NCT06923774Recruiting
- Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma
NCT06563362RecruitingPhase 2
- Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
NCT07223814RecruitingPhase 3
- A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
NCT07522073RecruitingPhase 3
- Anti-GD2 ADC M3554 in Advanced Solid Tumors
NCT06641908RecruitingPhase 1
- Vorasidenib Maintenance for IDH Mutant Astrocytoma
NCT06809322RecruitingPhase 3
- Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
NCT06697301RecruitingPhase 2 · Phase 3
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06760819RecruitingPhase 2
- A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT06973187RecruitingPhase 3
- A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
NCT05160584Recruiting
- This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401RecruitingPhase 3
- A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
NCT05748171RecruitingPhase 2
- Visugromab in Cachexia International Trial
NCT07112196RecruitingPhase 2 · Phase 3
- Pharmacoscopy for Patients With Refractory Primary Brain Tumors
NCT06804655RecruitingPhase 2
- Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II Study
NCT07832123Not yet recruitingPhase 2
- Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
NCT07778316RecruitingPhase 3
- Real-Time Breath Analysis in Acute Myeloid Leukaemia for a Rapid Characterisation of Biological Subtypes and to Predict Therapy Responses
NCT07826897Not yet recruiting
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT06492616RecruitingPhase 3
- Lung cAncer Robotic Comparative Study
NCT06038227Recruiting
- Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC
NCT07026474RecruitingPhase 3
- Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
NCT01949129RecruitingPhase 2 · Phase 3
- Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
NCT06652438RecruitingPhase 3
- What Impact Does an Initial Psycho-oncological Contact Have on People With Cancer?
NCT07544446Recruiting
- Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
NCT07058805RecruitingPhase 2
- Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney Transplant Recipients Receiving an Organ From EBV Positive Donors
NCT07368153RecruitingPhase 2
- Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
NCT05183035RecruitingPhase 3
- Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)
NCT07782112Not yet recruitingPhase 3
- Weekly Online CT or MR Adaptive Definitive SBRT for Regionally Metastatic Prostate Cancer
NCT07591051Not yet recruiting
- Comparing Closed Face Masks vs Surface Guided Radiation Therapy for Head and Neck Radiotherapy
NCT06870799Recruiting
- DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Recruiting
- ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
NCT06801899Recruiting
- A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
NCT06926868RecruitingPhase 2 · Phase 3
- Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
NCT07106762RecruitingPhase 2 · Phase 3
- Structured Case-Finding for Pancreatic Ductal Adenocarcinoma in Swiss Primary Care: A Feasibility Study
NCT07723781Not yet recruiting
- A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
NCT05253651RecruitingPhase 3
- AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
NCT07218809RecruitingPhase 3
- DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
NCT07717437Recruiting
- Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
NCT07617610Recruiting
- FAPI PET Imaging - An Exploratory Study
NCT07705074Not yet recruitingPhase 1 · Phase 2
- First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT06217822RecruitingPhase 1
- Daily Adjustment of the Radiation Dose in MRI-guided Stereotactic Radiotherapy for Tumors in the Abdominal and Pelvic Regions
NCT07687147Recruiting
- Assessment of Metabolic Changes in Response to Glcuose Intake in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS)
NCT07687264Not yet recruiting
- Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer
NCT06834152Recruiting
- Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer
NCT07042256Recruiting
- A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
NCT05131022RecruitingPhase 1
- Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial
NCT05508464Recruiting
- Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases
NCT06620380RecruitingPhase 2
- Vortioxetine for Newly Diagnosed Glioblastoma
NCT07284628RecruitingPhase 2
- Combination Therapy for the Treatment of Diffuse Midline Gliomas
NCT05009992RecruitingPhase 2
- SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
NCT02834884Recruiting
- Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
NCT05700149Recruiting
- 177Lu-DOTATATE for Recurrent Meningioma
NCT06326190RecruitingPhase 2
- ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
NCT04732065RecruitingPhase 1
- Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
NCT05904119RecruitingPhase 3
- Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging
NCT07624760Not yet recruiting
- Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
NCT05815927RecruitingPhase 3
- A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
NCT06256588RecruitingPhase 3
- Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer
NCT06274879RecruitingPhase 2
- A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
NCT06284317RecruitingPhase 3
- A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection
NCT06291896Recruiting
- Early Pulmonary Dysfunction in Childhood Cancer Patients
NCT05427136Recruiting
- International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
NCT04043494RecruitingPhase 3
- Neoadjuvant Darovasertib in Primary Uveal Melanoma
NCT07015190RecruitingPhase 3
- ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
NCT04916613RecruitingPhase 3
- Save the Ovaries - Surgical Management of Simple Ovarian Cysts in Children and Adolescents
NCT06852313Recruiting
- Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
NCT05522660RecruitingPhase 3
- ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
NCT05580562RecruitingPhase 3
- First in Human Study of T3P-Y058-739 (T3P)
NCT05120596RecruitingPhase 1 · Phase 2
- Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients
NCT06114108Recruiting
- Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
NCT07494864Recruiting
- Screening for Brain Metastases
NCT07492121Not yet recruitingPhase 2
- A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
NCT04988555RecruitingPhase 1 · Phase 2
- Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)
NCT07472972Recruiting
- Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision
NCT02280889Recruiting
- Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
NCT05549297RecruitingPhase 3
- IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
NCT06112314RecruitingPhase 3
- Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
NCT03463954Recruiting
- Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
NCT07263438RecruitingPhase 2
- Post-Market Study of Transbronchial Cryo-assisted RFA During Robotic Bronchoscopy With Subsequent Surgical Resection
NCT07398027Not yet recruiting
- A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
NCT05717166RecruitingPhase 3
- Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)
NCT06835049RecruitingPhase 2
- Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)
NCT07309497Recruiting
- Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.
NCT06479070Recruiting
- Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
NCT06680050RecruitingPhase 2
- Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT03567889RecruitingPhase 3
- Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
NCT05259605Recruiting
- PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
NCT06102057RecruitingPhase 2
- HOPE Against Cancer Recurrence in HCC
NCT06717919RecruitingPhase 4
- VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
NCT04057209Recruiting
- MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
NCT04111978RecruitingPhase 3
- HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
NCT05658640RecruitingPhase 1 · Phase 2
- Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
NCT07075016RecruitingPhase 3
- MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery
NCT06815289Recruiting
- OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
NCT06462963Recruiting
- The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer
NCT05894070Recruiting
- SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
NCT05192980Recruiting
- Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof
NCT06108375Recruiting
- DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
NCT06615349Recruiting
- Restrictive Use of Dexamethasone in Glioblastoma
NCT04266977Recruiting
- Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.
NCT06776172Recruiting
- Evaluation of the Efficacy of Compression With Tight Surgical Gloves in Patients With Taxane-based Therapy
NCT06464536Recruiting
- The Dragon PLC Trial (DRAGON-PLC)
NCT06914648Recruiting
- Effects of Intranasal Ketamine on Depression and Anxiety in Palliative Care Cancer Patients
NCT06665568Not yet recruitingEarly phase 1
- SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New
NCT06931847Not yet recruiting
- A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
NCT04775485RecruitingPhase 2
- Breath Analysis for the Detection of Invasive Fungal Infections
NCT06537726Recruiting
- The SUNRISE Project is Dedicated to Enhancing Primary Cancer Prevention Among Adolescents in Europe by Leveraging Innovative Digital Tools and Methodologies. SmartCoach, Developed by Swiss Research Institute for Public Health and Addiction (ISGF), is a Mobile Phone-based Life-skills Training Program
NCT06922201Not yet recruiting
- Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
NCT03643276RecruitingPhase 3
- Caregiver Stress and Bereavement
NCT05867706Recruiting
- E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
NCT03818503Recruiting
- Swiss Severe Asthma Register
NCT03984253Recruiting
- Response Assessment During MR-guided Radiation Therapy for Glioblastoma
NCT05565326Recruiting
- EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases
NCT05688241Not yet recruitingPhase 1 · Phase 2
- Imaging Quality and Potential Clinical Relevance of Phase Contrast Mammography In-vivo: a Single-center, Prospective Study
NCT06489665Recruiting
- PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
NCT05055648RecruitingPhase 3
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT05017142Recruiting
- Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
NCT05502380RecruitingPhase 3
- Research Collaboration for a Precision Oncology Program (POP)
NCT06680726Recruiting
- Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer
NCT04289935Recruiting
- Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
NCT04498767Recruiting
- Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies
NCT06550102Recruiting
- Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma
NCT03222635Recruiting
- Mastocytosis Registry (of Zurich)
NCT06466889Recruiting
- Therapy-Associated Saliva and Taste Change Evaluation (TASTE) in Head & Neck Cancer Patients Undergoing Radiotherapy
NCT06444776Recruiting
- Cerebrovascular Disease: Quality of Life (CODE: QoL)
NCT06443268Recruiting
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT04625907RecruitingPhase 1 · Phase 2
- Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis
NCT06417710Recruiting
- Glutamate Inhibitors in Glioblastoma
NCT05664464RecruitingPhase 1 · Phase 2
- Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
NCT06360627Recruiting
- Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
NCT04300257Recruiting
- Single-isocenter SBRT vs. Multiple-isocenter SBRT for Multiple Extracranial Metastases
NCT06230666Recruiting
- INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
NCT03838042RecruitingPhase 1 · Phase 2
- Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
NCT04443010RecruitingPhase 1 · Phase 2
- Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
NCT04045691Recruiting
- Multicenter Pheochromocytoma and Paraganglioma Evaluation
NCT03344016Recruiting